| Financial Year |
March 31 2023 |
| Monetary Funds |
380,125,293.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
16,106,351.58 |
| Advances to Suppliers |
9,915,482.28 |
| Other Receivables |
99,709,087.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,918,676,985.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
308,141,569.53 |
| Total Current Assets |
9,732,674,769.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
173,798,850.68 |
| Investment Properties |
304,647,206.89 |
| Fixed Assetes |
2,497,177,449.17 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
219,451,901.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
27,060,360.18 |
| Deferred Income Tax Assets |
165,386,942.99 |
| Other Non-Current Assets |
185,829,970.24 |
| Sub-Total of Non-Current Assets |
3,676,512,476.92 |
| Total Assets |
13,409,187,246.61 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,170,491,126.71 |
| Accounts Received In Advance |
4,313,103.88 |
| Employee Compensation Payable |
2,916,155.04 |
| Taxes Payable |
171,889,037.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
941,333,457.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,661,961,654.62 |
| Other Current Liabilities |
112,217,102.78 |
| Sub-Total of Current Liabilities |
5,478,382,822.01 |
| Long-term Loans |
2,735,611,542.94 |
| Bonds Payable |
813,570,791.00 |
| Long-Term Accounts Payable |
654,054,875.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,795,442.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,226,365,411.32 |
| Total Liabilities |
9,704,748,233.33 |
| Paid-In Capital(Or Share Stock) |
819,660,744.00 |
| Capital Surplus |
1,641,646,749.09 |
| Surplus Reserve |
35,990,124.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,244,251,502.47 |
| Minority Stockholder's Interest |
-101,654,953.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,806,093,966.98 |
| Owner's Equity（Stockholder's Equity） |
3,704,439,013.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,409,187,246.61 |
